Ibex Wealth Advisors Raises Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)
Ibex Wealth Advisors lifted its position in Medical Properties Trust, Inc. (NYSE:MPW) by 1.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 152,743 shares of the real estate investment trust’s stock after buying an additional 2,798 shares during the quarter. Ibex Wealth Advisors’ holdings in Medical Properties Trust were worth $3,224,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of MPW. SPC Financial Inc. acquired a new stake in Medical Properties Trust during the 4th quarter valued at approximately $218,000. Pegasus Asset Management Inc. lifted its position in Medical Properties Trust by 2.0% in the fourth quarter. Pegasus Asset Management Inc. now owns 107,997 shares of the real estate investment trust’s stock valued at $2,280,000 after buying an additional 2,078 shares during the last quarter. Optimum Investment Advisors lifted its position in Medical Properties Trust by 12.4% in the fourth quarter. Optimum Investment Advisors now owns 47,891 shares of the real estate investment trust’s stock valued at $1,011,000 after buying an additional 5,300 shares during the last quarter. MONECO Advisors LLC acquired a new position in Medical Properties Trust in the fourth quarter valued at about $323,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Medical Properties Trust by 200.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 347,308 shares of the real estate investment trust’s stock valued at $7,332,000 after buying an additional 231,587 shares during the last quarter. 71.98% of the stock is currently owned by hedge funds and other institutional investors.
Shares of MPW traded down $0.11 during mid-day trading on Friday, hitting $22.40. 94,887 shares of the company’s stock were exchanged, compared to its average volume of 2,767,681. The company has a market cap of $11.58 billion, a price-to-earnings ratio of 27.65, a P/E/G ratio of 3.07 and a beta of 0.51. Medical Properties Trust, Inc. has a fifty-two week low of $16.83 and a fifty-two week high of $22.65. The company has a debt-to-equity ratio of 1.02, a quick ratio of 6.27 and a current ratio of 6.27. The stock’s 50-day moving average is $21.06 and its 200-day moving average is $19.61.
The company also recently announced a quarterly dividend, which was paid on Thursday, January 9th. Investors of record on Thursday, December 12th were paid a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, December 11th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 4.64%. Medical Properties Trust’s payout ratio is 75.91%.
In other news, insider Holzgrefe Richard bought 500,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average cost of $0.09 per share, for a total transaction of $44,500.00. Also, COO Emmett E. Mclean sold 100,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 8th. The stock was sold at an average price of $20.84, for a total transaction of $2,084,000.00. Following the sale, the chief operating officer now owns 1,003,415 shares in the company, valued at $20,911,168.60. The disclosure for this sale can be found here. 1.18% of the stock is currently owned by corporate insiders.
MPW has been the topic of a number of recent analyst reports. Barclays set a $22.00 target price on shares of Medical Properties Trust and gave the company a “buy” rating in a research report on Monday, October 21st. TheStreet cut shares of Medical Properties Trust from a “b” rating to a “c+” rating in a research report on Monday, November 25th. Mizuho increased their price target on shares of Medical Properties Trust from $25.00 to $26.00 and gave the stock a “buy” rating in a research report on Thursday, December 26th. ValuEngine raised shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, December 3rd. Finally, Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research report on Wednesday, January 8th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $21.35.
Medical Properties Trust Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Story: What is diluted earnings per share (Diluted EPS)?
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.